Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Epigenetic Therapy in Oncology Analytical Tool - Research and Markets

Research and Markets
Posted on: 12 Oct 16

Research and Markets has announced the addition of the "Epigenetic Therapy in Oncology: Analytical Tool" report to their offering.

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.

The Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:

- Target Scouting

- Early & Late Stage Pipeline Analysis

- Biomarker/Companion Diagnostic Analysis

- Deal & Alliance Analysis

- Combination Therapy Analysis

- Indication Selection & Expansion Analysis

- First-in-Class Analysis

- Drug Repositioning

- Pipeline Analysis by Targeted Pathways

For more information about this report visit

View source version on

Business Wire

Last updated on: 12/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.